13F HOLDINGS REPORT
Flagship Pioneering Inc.
Quarter ended Q3 2024 · Filed November 14, 2024 · Accession 0000950123-24-011756
Total Value
$591.9M
Positions
12
Other Managers
3
Confidential Omitted
No
Holdings (12)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Moderna Inc | MRNA | 4,628,225 | $309.3M | 52.26% |
| 2 | Foghorn Therapeutics Inc | FHTX | 9,330,878 | $86.9M | 14.68% |
| 3 | Sana Biotechnology Inc | SANA | 15,909,178 | $66.2M | 11.18% |
| 4 | Sana Biotechnology Inc | SANA | 9,092,678 | $37.8M | 6.39% |
| 5 | Foghorn Therapeutics Inc | FHTX | 3,343,242 | $31.1M | 5.26% |
| 6 | Omega Therapeutics Inc | 68217N105 | 22,240,723 | $27.1M | 4.58% |
| 7 | Seres Therapeutics Inc | MCRB | 14,664,169 | $13.9M | 2.34% |
| 8 | Omega Therapeutics Inc | 68217N105 | 6,984,856 | $8.5M | 1.44% |
| 9 | Seres Therapeutics Inc | MCRB | 8,452,876 | $8.0M | 1.35% |
| 10 | Syros Pharmaceuticals Inc | 87184Q206 | 1,000,000 | $2.1M | 0.36% |
| 11 | Syros Pharmaceuticals Inc | 87184Q206 | 293,849 | $631,776 | 0.11% |
| 12 | Moderna Inc | MRNA | 3,924 | $262,241 | 0.04% |